Alto Neuroscience, Inc. (ANRO) financials · $60.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Alto Neuroscience, Inc. (ANRO) $60.1M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$66.4M | -$68.6M |
| Net Income | -$63.2M | -$61.4M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $184.7M | $177.5M |
| Current Assets | $177.7M | $169.3M |
| Cash & Equivalents | $176.5M | $168.2M |
| PP&E | $1.87M | $2.67M |
| Total Liabilities | $33.5M | $26.1M |
| Current Liabilities | $11.3M | $10.0M |
| Short-term Debt | $585.0K | N/A |
| Long-term Debt | $16.2M | $10.3M |
| Total Debt | $16.8M† | $10.3M† |
| Shareholders' Equity | $151.1M | $151.5M |
| Retained Earnings | -$201.6M | -$138.4M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$51.8M | -$47.4M |
| CapEx | $24.0K | $2.08M |
| Investing Cash Flow | -$24.0K | -$2.08M |
| Financing Cash Flow | $60.1M | $135.7M |
| Net Change in Cash | $8.26M | $86.2M |
| Free Cash Flow | -$51.8M | -$49.5M |
FAQ
What is ANRO P/E and revenue?
Alto Neuroscience, Inc. (ANRO) $60.1M cap.
What is ANRO revenue?
ANRO income-statement cache has no revenue figure yet.
Is ANRO profitable?
Alto Neuroscience, Inc. last cached net income is -$63.2M (FY2025).
What are ANRO total assets?
Alto Neuroscience, Inc. last cached total assets are $184.7M (FY2025).
What is ANRO free cash flow?
Alto Neuroscience, Inc. last cached free cash flow is -$51.8M (FY2025).
Not investment advice. Cached statements, not a live tape.